Search Results 261-270 of 16473 for senescent cells senolytic
Mayo Clinic's T Cell Engineering Lab of Saad J. Kenderian, M.B., Ch.B., studies engineered virus and cell, chimeric antigen receptor (CAR)-T cell therapy.
The therapy, IC19/1563, uses some of the patients own immune cells, called T cells, to kill cancer. T cells fight infections and, in some cases, can also kill ...
Endometrial cancer, the most common uterine cancer, starts with abnormal cell growth in the endometrium. Significant risk factors include polycystic ovary ...
About this study. RATIONALE: Giving chemotherapy before an autologous stem cell transplant stops the growth of cancer cells by stopping them from dividing ...
Mayo Clinic's Translational Cell Biology of Parkinson's Disease Lab led by Wolfdieter Springer, Ph.D., studies the molecular roles underlying ...
This is a prospective study for the long-term follow-up (LTFU) of safety and efficacy for all pediatric and adult subjects exposed to Gene-modified (GM) T cell ...
The primary objective of this study is to investigate the contribution of group 2 innate lymphoid cells (ILC2s) to the immunologic mechanisms of chronic airway ...
Learn about this cancer that forms from white blood cells called plasma cells. Treatments include medicines and bone marrow transplant.
About this study. The purpose of this research protocol is to systematically investigate the optimal conditions for isolating and culturing (referred to as ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.